Fu Y., et al. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nature Biotechnology, 2014 Jan 26; doi: 10.1038/nbt2808. [Epub ahead of print]

Oct

3

Editas Medicine Announces $50+ Million Monetization Financing with DRI Healthcare Trust

Aug

28

Editas Medicine to Participate in Upcoming Investor Conferences

Aug

7

Editas Medicine Announces Second Quarter 2024 Results and Business Updates